Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
76%
Infection
61%
Chagas Disease
57%
African Trypanosomiasis
51%
Trypanosoma Brucei
46%
Sphingosine 1 Phosphate Receptor
46%
Trypanosoma Cruzi
40%
Mouse
34%
Ponesimod
34%
Pyrazole
34%
Structure Activity Relationship
34%
Cytotoxicity
34%
Oxidoreductase
34%
Therapeutic Window
34%
Benznidazole
34%
Mouse Model
34%
Tuberculosis
30%
Piperazine Derivative
23%
Phenol
23%
Sulfonamide
23%
Lysine Transfer RNA Ligase
23%
Quinazolinone Derivative
23%
Opiate
23%
Tablet
23%
Amine Oxidase (Copper Containing)
23%
Aldehyde Dehydrogenase
23%
Amitrole
23%
Benzaldehyde
23%
Topical Agent
23%
Disease
23%
Host
23%
Antitrypanosomal Agent
23%
Functional Groups
23%
Aldo Keto Reductase
23%
Trypanosomatidae
23%
Methylglyoxal
23%
Carboxamide
23%
Carboxylate
23%
Side Effect
23%
Antitrypanosomal
23%
Tropical Disease
23%
Ion Channel
23%
Cryptosporidiosis
23%
Methylamine
23%
Kinetoplastida
23%
Prodrug
23%
Antiinfective Agent
23%
Polyketide Synthase
23%
Prostaglandin
23%
Isoprostane Derivative
23%
Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Chagas Disease
57%
Soft Drugs
46%
Sphingosine-1-phosphate Receptor (S1PR)
46%
Trypanosoma Cruzi (T. cruzi)
46%
Metabolism
46%
Pks13
34%
Benznidazole
34%
Human African Trypanosomiasis
32%
Structure-activity Relationship
30%
Mechanism of Action
30%
Thioesterase
28%
Benzofuran
28%
New Drugs
28%
Mouse Model
27%
HERG
26%
Trypanosoma Brucei
26%
Ponesimod
25%
Esters
25%
Inhibitor Identification
23%
Mercapto
23%
Cytotoxicity Profile
23%
Spirocycles
23%
MmpL3 Inhibitor
23%
Disubstituted piperazines
23%
Lysine Acetylome
23%
Relationship Mechanism
23%
Type II NADH Dehydrogenase
23%
Absorption Mechanism
23%
MT-45
23%
Fluorinated Analogs
23%
Metabolite Discovery
23%
Polyketide Synthase 13
23%
Benzoxaborole
23%
Aminomethyl
23%
Host-parasite
23%
Cometabolic
23%
1,2,3-Triazole-4-carboxamide
23%
Proteomic Approach
23%
Absorption Distribution
23%
Potential Treatments
23%
Aldo-keto Reductase
23%
Aspirin
23%
Morpholino
23%
Methyltransferase
23%
Guanine
23%
Malaria
23%
μ-opioid Receptor
23%
Penetrant
23%
Inhibitor Evaluation
23%
Medicine and Dentistry
Disease
34%
Mycobacterium Tuberculosis
34%
African Trypanosomiasis
28%
Enzymatic Hydrolysis
23%
Sphingosine 1 Phosphate Receptor
23%
Ponesimod
23%
Pyrazole
23%
Phenol Derivative
23%
Benzofuran Derivative
23%
Guanine
23%
Thiophene Derivative
23%
Topical Drug Administration
23%
Methylglyoxal
23%
Trypanosoma Brucei
23%
Trypanosomatid
23%
Central Nervous System
23%
Sulfonamide
23%
Dermatitis
23%
Benznidazole
23%
Phenol
23%
Parasite (Microbiology)
23%
Thiol Ester Hydrolase
23%
Aldo Keto Reductase
23%
Methyltransferase
23%
Prostaglandin
23%
Isoprostane Derivative
23%
Prostaglandin F2
17%
Glyoxal
17%
Ion Channel
11%
Cytochrome C
11%
Patient Population
11%
Phenotypic Screening
11%
Chagas Disease
11%
In Vitro
11%
Ex Vivo
11%
Arachidonic Acid
11%
Oxidoreductase
11%
Cytotoxicity
11%
Cell Activity
11%
Structure-Activity Relationship
11%
Whole Cell
11%
Cardiotoxicity
11%
Infection
11%
Therapeutic Window
11%
Action Study
11%
Drug Resistance
11%
Cytochrome C Oxidase
11%
Thiophene
11%
Capping Phenomenon
5%
Cross-Link
5%